Related Experiment Videos
Trisomy 12 in chronic lymphocytic leukemia: an interphase cytogenetic study
A P Losada1, M Wessman, M Tiainen
1Department of Medical Genetics, University of Helsinki, Finland.
Blood
|August 1, 1991
Summary
Interphase cytogenetics reveals trisomy 12 is more common in chronic lymphocytic leukemia than previously thought. This advanced technique improves detection of chromosomal abnormalities for better prognostic evaluation.
Area of Science:
- Hematology
- Cytogenetics
- Molecular Biology
Background:
- Chronic lymphocytic leukemia (CLL) is the most common adult leukemia.
- Trisomy 12 is a frequent chromosomal abnormality in CLL.
- Conventional karyotype analysis may underestimate the incidence of trisomy 12.
Purpose of the Study:
- To investigate the incidence of trisomy 12 in CLL using interphase cytogenetics.
- To compare the diagnostic power of interphase cytogenetics with conventional karyotyping.
- To assess the utility of trisomy 12 detection for prognostic evaluation.
Main Methods:
- Interphase cytogenetics utilizing a chromosome 12-specific biotinylated alpha satellite DNA probe (pSP 12-1).
- In situ hybridization performed on fixed cells from conventional cytogenetic and cytospin preparations.
- Immunophenotyping to characterize cell populations.
Main Results:
- Trisomy 12 was detected in 2 of 13 patients with normal karyotypes by G-banding analysis.
- Interphase cytogenetics identified trisomy 12 more frequently than metaphase karyotyping.
- In one case, trisomy 12 was found to be restricted to clonally selected cells.
Conclusions:
- Interphase cytogenetics is a more sensitive method for detecting trisomy 12 in CLL.
- This technique should complement karyotype analysis for comprehensive assessment.
- Accurate detection of trisomy 12 is crucial for understanding its prognostic, therapeutic, and biologic significance in CLL.